Clinical Trials on Histologically-confirmed Malignancies in United Kingdom
Total 875 results
-
AstraZenecaRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Spain, Australia, Sweden, Germany, United Kingdom
-
AstraZenecaTerminatedStudy of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological MalignanciesHaematological MalignanciesFrance, Italy, United States, Korea, Republic of, Germany, Australia
-
National Cancer Institute (NCI)TerminatedMelanoma | Sarcoma | Epithelial Malignancies | Pleural MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingPleural Metastases | Thymic MalignanciesUnited States
-
Fred Hutchinson Cancer CenterRecruitingHematopoietic and Lymphoid Cell NeoplasmUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematological MalignanciesUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownHematopoietic and Lymphoid Cell NeoplasmUnited States
-
St. Jude Children's Research HospitalMichigan State UniversityCompletedHematologic MalignanciesUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; BiogenCompleted
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedSolid Tumors | Hematological MalignanciesUnited States
-
Kiadis PharmaCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeCanada, Germany, Belgium, United Kingdom
-
BeiGeneCompletedB-cell Lymphoid MalignanciesAustralia, Korea, Republic of, United States
-
Roswell Park Cancer InstituteRecruitingHematopoietic and Lymphoid System NeoplasmUnited States
-
Stefanie Sarantopoulos, MD, PhD.CompletedHematological MalignanciesUnited States
-
Massachusetts General HospitalMedically HomeActive, not recruiting
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedHematologic MalignancyUnited States
-
Massachusetts General HospitalActive, not recruitingHematologic Malignancy | CAR-T Cell TherapyUnited States
-
Firas El Chaer, MDRecruitingHematologic Malignancy | Platelet RefractorinessUnited States
-
Northside Hospital, Inc.RecruitingTransplant-Related Hematologic MalignancyUnited States
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); National Institute of General Medical Sciences...RecruitingAll Malignancies | Children Being Treated for Catastrophic IllnessUnited States
-
Mayo ClinicCompleted
-
Mayo ClinicEnrolling by invitation
-
University of ChicagoTerminatedHematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterBTG International Inc.Terminated
-
Millennium Pharmaceuticals, Inc.CompletedCarcinoma, Basal Cell | Advanced Nonhematologic MalignanciesUnited States
-
Scripps Translational Science InstituteCompleted
-
Nationwide Children's HospitalRecruitingHematologic Malignancy | Hematopoietic Stem Cell TransplantationUnited States
-
Dana-Farber Cancer InstituteCompletedHematologic MalignancyUnited States
-
National Cancer Institute (NCI)WithdrawnHematopoietic Stem Cell Transplantation | Hematologic Malignancies | Cell TransplantationUnited States
-
St. Jude Children's Research HospitalAssisi Foundation; The Hartwell FoundationCompletedHematologic Malignancies | Disorder Related to Transplantation | Hematopoietic MalignancyUnited States
-
Wake Forest University Health SciencesMuscular Dystrophy AssociationCompletedMuscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED)United States
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, China, Japan, Taiwan, Australia, Germany
-
Kangpu Biopharmaceuticals, Ltd.RecruitingHematological MalignanciesUnited States
-
Duke UniversityRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Symptomatic COVID-19 Infection Laboratory-ConfirmedUnited States
-
SecuraBioCompletedHematologic MalignancyUnited States, Italy
-
Fate TherapeuticsTerminatedHematological MalignancyUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingHematopoietic/Lymphoid Cancer | Hematologic Malignancy | Blood CancerUnited States
-
St. Jude Children's Research HospitalAssisi FoundationCompletedLymphoma | LeukemiaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Beth Israel Deaconess Medical Center; Brigham...CompletedHematologic MalignancyUnited States
-
Spectrum Pharmaceuticals, IncOnxeoCompletedSolid Tumor | Hematological MalignancyUnited States
-
Century Therapeutics, Inc.RecruitingHematological Malignancy | Solid Tumor MalignancyUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...RecruitingHematopoietic and Lymphoid Cell NeoplasmUnited States
-
City of Hope Medical CenterNational Institute on Aging (NIA)Active, not recruitingCancer | Solid Tumor | Hematologic MalignancyUnited States
-
PfizerMedivation, Inc.CompletedAcute Myeloid Leukemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic SyndromeUnited Kingdom, United States
-
Incyte CorporationCompletedAdvanced MalignanciesUnited States
-
Incyte CorporationCompletedSolid Tumors and Hematologic MalignancyUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Symptomatic COVID-19 Infection Laboratory-ConfirmedUnited States
-
Emory UniversityNational Cancer Institute (NCI)Active, not recruitingSevere Acute Respiratory Syndrome | Pneumonia | Symptomatic COVID-19 Infection Laboratory-ConfirmedUnited States
-
Brigham and Women's HospitalHarvard Medical School (HMS and HSDM)CompletedHematopoietic/Lymphoid Cancer | Hematologic Malignancy | Blood CancerUnited States